Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Louis

Showing results (31-40 of 290) with videos related to

Pageof 29
Sort By:
Current Drug Targets|March 10, 2010
Anti-TNF and Crohn's disease: when should we stop?Edouard Louis, Jacques Belaiche, Catherine Reenaers
Scandinavian Journal of Gastroenterology|December 17, 2008
Predictors of severe Crohn's diseaseCatherine Loly, Jacques Belaiche, Edouard Louis
Inflammatory Bowel Diseases|September 26, 2008
Does the behavior of Crohn's disease change over time?Edouard Louis, Catherine Reenaers, Jacques Belaiche
Therapeutic Advances in Gastroenterology|December 25, 2010
Tailoring the treatment to the individual in Crohn's diseaseEdouard Louis, Jacques Belaiche, Catherine Reenaers
Expert Review of Gastroenterology & Hepatology|September 24, 2015
The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13Walter Reinisch, Edouard Louis, Silvio Danese
JAMA|January 22, 2025
Risankizumab for Ulcerative Colitis-ReplyEdouard Louis, Jasmina Kalabic, Edward V Loftus
Journal of Crohn'S & Colitis|February 23, 2021
Tofacitinib De-escalation Strategy in Ulcerative Colitis: Is It the End of the Story?Lucas Guillo, Laurent Peyrin-Biroulet, Edouard Louis
Gastroenterology|March 24, 2020
Looking for Innovative Digital Solutions to Optimize Patient Recruitment in Inflammatory Bowel Disease TrialsYoram Bouhnik, Edouard Louis, Laurent Peyrin-Biroulet
Best Practice & Research. Clinical Gastroenterology|June 7, 2011
Necessity of phenotypic classification of inflammatory bowel diseaseEdouard Louis, Catherine Van Kemseke, Catherine Reenaers
European Journal of Nuclear Medicine and Molecular Imaging|February 10, 2023
Commentary to "[<sup>68</sup> Ga]Ga-FAPI-04 PET/CT on assessing Crohn's disease intestinal lesions" by Chen and colleaguesPierre Lovinfosse, Sophie Vieujean, Edouard Louis, et al.
Pageof 29

Showing results (31-40 of 290) with videos related to

Sort By:
Pageof 29
Current Drug Targets|March 10, 2010
Anti-TNF and Crohn's disease: when should we stop?Edouard Louis, Jacques Belaiche, Catherine Reenaers
Scandinavian Journal of Gastroenterology|December 17, 2008
Predictors of severe Crohn's diseaseCatherine Loly, Jacques Belaiche, Edouard Louis
Inflammatory Bowel Diseases|September 26, 2008
Does the behavior of Crohn's disease change over time?Edouard Louis, Catherine Reenaers, Jacques Belaiche
Therapeutic Advances in Gastroenterology|December 25, 2010
Tailoring the treatment to the individual in Crohn's diseaseEdouard Louis, Jacques Belaiche, Catherine Reenaers
Expert Review of Gastroenterology & Hepatology|September 24, 2015
The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13Walter Reinisch, Edouard Louis, Silvio Danese
JAMA|January 22, 2025
Risankizumab for Ulcerative Colitis-ReplyEdouard Louis, Jasmina Kalabic, Edward V Loftus
Journal of Crohn'S & Colitis|February 23, 2021
Tofacitinib De-escalation Strategy in Ulcerative Colitis: Is It the End of the Story?Lucas Guillo, Laurent Peyrin-Biroulet, Edouard Louis
Gastroenterology|March 24, 2020
Looking for Innovative Digital Solutions to Optimize Patient Recruitment in Inflammatory Bowel Disease TrialsYoram Bouhnik, Edouard Louis, Laurent Peyrin-Biroulet
Best Practice & Research. Clinical Gastroenterology|June 7, 2011
Necessity of phenotypic classification of inflammatory bowel diseaseEdouard Louis, Catherine Van Kemseke, Catherine Reenaers
European Journal of Nuclear Medicine and Molecular Imaging|February 10, 2023
Commentary to "[<sup>68</sup> Ga]Ga-FAPI-04 PET/CT on assessing Crohn's disease intestinal lesions" by Chen and colleaguesPierre Lovinfosse, Sophie Vieujean, Edouard Louis, et al.
Pageof 29